What is the CVR number of Draupnir Bio ApS?

Draupnir Bio ApS is registered with CVR / Virk under CVR 38546880.

What is the revenue of Draupnir Bio ApS?

Draupnir Bio ApS reported revenue of DKK 45,1M in 2025.

Draupnir Bio ApS employs 12 people as of the latest annual report.

Eva-Lotta Coulter chairs the board of Draupnir Bio ApS, in role since 2021.

Draupnir Bio ApS's registered address is Nordre Fasanvej 215.

APSActiveAdvertising protection

CVR 38546880Nordre Fasanvej 215, 2000 FrederiksbergResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2017 · 9 years old12 employeeswww.draupnir.bio

Actively employed in the business

Name	Role	Member since
Current (1)
AT Andrew Thomas Hotchkiss Management	Management	2021

Non-executive oversight

Name	Role	Member since
Current (6)
SE Stefan Emanuel Luzi Board of Directors	Board of Directors	2019
IB Ivan Burkov Board of Directors	Board of Directors	2022
EC Emmanuelle Coutanceau Board of Directors	Board of Directors	2021
SG Simon Glerup Pedersen Board of Directors	Board of Directors	2019
RA Robert Andrew Donald Scott Board of Directors	Board of Directors	2020
EC Eva-Lotta Coulter Chairman	Chairman	2021
Former (5)
PS Peder Søndergaard Madsen Chairman	Chairman	2017 – 2018
FM Fiona MacLaughlin Board of Directors	Board of Directors	2019 – 2020
CG Camilla Gustafsen Board of Directors	Board of Directors	2017 – 2018
RB Roel Bulthuis Board of Directors	Board of Directors	2020 – 2022
PH Peter Hans Andreas Seeberger Board of Directors	Board of Directors	2018 – 2019

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Novo Holdings A/S	Company	20–24.99%	20–24.99%	2024
Stichting Depositary INKEF Investment Fund	Individual	20–24.99%	20–24.99%	2024
Coöperatieve Gilde Healthcare IV U.A.	Individual	20–24.99%	20–24.99%	2024
Danmarks Eksport- og Investeringsfond	Company	10–14.99%	10–14.99%	2024
MP Healthcare Venture Management, Inc,	Individual	10–14.99%	10–14.99%	2024
High-Tech Gründerfonds III GmbH & Co. KG	Individual	5–9.99%	5–9.99%	2019
Seeberger Science GmbH	Individual	5–9.99%	5–9.99%	2019

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.